...
首页> 外文期刊>Journal of Neurology >Attitudes and barriers to clinical practice guidelines in general and to the guideline on Parkinson’s disease. A National Survey of German neurologists in private practice
【24h】

Attitudes and barriers to clinical practice guidelines in general and to the guideline on Parkinson’s disease. A National Survey of German neurologists in private practice

机译:一般临床实践指南和帕金森氏病指南的态度和障碍。一项针对德国神经科医生私人执业的全国调查

获取原文
获取原文并翻译 | 示例

摘要

Although much progress has been made in the development of clinical practice guidelines (CPGs), there are few strategies for dissemination and implementation of these guidelines. This study examines the attitudes of neurologists to CPGs and barriers to CPG implementation, with a particular focus on the Parkinson’s disease CPG (PD-CPG). A cross-sectional survey was performed in 2007 with a representative sample of 213 neurologists in private practice in Germany. The main outcome measures were the Tunis Attitudinal Scale and barrier assessment of CPGs. In addition, the awareness, applicability, and usefulness of the PD-CPG were assessed. Most of the neurologists agreed that CPGs are intended to improve the quality of care (82.2%; n = 171), are good educational tools (59.4%; n = 120), and are an unbiased synthesis of expert opinion (58.9%; n = 119). The main barriers to guideline implementation were lack of time (39.3%; n = 81), inability to reconcile patient preferences with guideline recommendations (34.3%; n = 71), and lack of awareness (32.5%; n = 67). A total of 187 (88.2%) of the neurologists were aware of the PD-CPG, of whom 163 (92.6%) found it “beneficial” and 173 (94.6%) applied it in daily practice. Nevertheless, only 51 (28.8%) of neurologists considered that the guidelines led to an improvement in the quality of care. However, 63 (32%) favored a special guideline for patients. Qualitative data analysis revealed more positive than negative aspects of the PD-CPG; positive comments included “treatment facilitation”, “a stepped therapy schema” and “increasing self-efficacy”. Criticism mostly concerned the lack of relevance to everyday practice and the rigidity of the guidelines. Neurologists in private practice have a generally positive attitude to guidelines. The PD-CPG is well-known and often used, but its impact on quality of care is considered to be only modest. Thus, further research is needed to address issues of daily practice in future versions of the PD-CPG and to investigate the effects of implementation at the physician and patient levels.
机译:尽管在临床实践指南(CPG)的开发方面已经取得了很大进展,但是几乎没有传播和实施这些指南的策略。这项研究调查了神经科医生对CPG的态度以及对CPG实施的障碍,特别关注了帕金森氏病CPG(PD-CPG)。 2007年进行了横断面调查,对德国213位私人执业神经科医生的代表性样本进行了调查。主要结果指标是突尼斯态度量表和CPG的障碍评估。另外,评估了PD-CPG的认识,适用性和有用性。大多数神经科医师同意,CPG旨在改善护理质量(82.2%; n = 171),是良好的教育工具(59.4%; n = 120),并且是专家意见的无偏见综合(58.9%; n) = 119)。实施指南的主要障碍是时间不足(39.3%; n = 81),无法将患者的喜好与指南建议相协调(34.3%; n = 71)和缺乏意识(32.5%; n = 67)。共有187名(88.2%)神经科医师知道PD-CPG,其中163(92.6%)认为PD-CPG是“有益的”,而173(94.6%)则将其用于日常实践。但是,只有51(28.8%)名神经科医生认为该指南可改善护理质量。但是,有63位(32%)赞成为患者提供特殊指南。定性数据分析显示,PD-CPG的正面方面比负面方面要好;积极评论包括“促进治疗”,“逐步治疗方案”和“提高自我效能”。批评主要涉及缺乏与日常实践的联系以及指南的僵化。私人执业的神经科医生对指导原则普遍持积极态度。 PD-CPG是众所周知的且经常使用,但是它对护理质量的影响被认为是很小的。因此,需要进行进一步的研究来解决PD-CPG未来版本中的日常实践问题,并研究在医生和患者层面实施的效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号